Peter Campochiaro, MD
Disclosures: Consulting Fee-Aerpio Therapeutics-Principal_Investigator Other_Role-Advisory board|Consulting Fee-Allergan-Other_Role-consultant|Consulting Fee-Applied Genetic Technologies Corporation-Other_Role-advisory board|Consulting Fee-AsclipiX-consultant|Consulting Fee-Genentech, Inc.-Other_Role-advisory board|Consulting Fee-Wave Life Sciences-Other_Role-consultant|Consulting Fee-Merck and Company, Inc.-Other_Role-consultant|Consulting Fee-Allegro-Other_Role-advisory board|Contracted Research-Regenxbio-Principal_Investigator|Contracted Research-Allergan-Principal_Investigator|Contracted Research-Genentech, Inc.-Principal_Investigator|Contracted Research-Genzyme Corporation-Principal_Investigator|Contracted Research-Oxford BioMedica-Principal_Investigator|Regeneron-Principal_Investigator|Consulting Fee-Exonate-Other_Role-advisory board|Consulting Fee-Novartis AG-Other_Role-consultant|Contracted Research-AsclipiX-Principal_Investigator|Consulting Fee-Graybug-Other_Role-consultant|Ownership Interest-Graybug
No Bio Available.